Skip to content

Breastfeeding Study

Characterization of Stool Consistency and Fecal Microbiota of Breastfed Infants

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03387124
Enrollment
75
Registered
2017-12-29
Start date
2018-01-22
Completion date
2018-12-11
Last updated
2019-04-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infant Term Birth

Brief summary

The purpose of this study is to evaluate the stool consistency and microbiota composition of healthy breastfed infants.

Detailed description

This is a prospective, observational, non-interventional study. The purpose of this study is to evaluate the stool consistency and variability in fecal microbiota composition, diversity, and abundance of defined taxa in 75 healthy, term, exclusively breastfed infants. All enrolled infants will participate in the trial for approximately 169 days.

Interventions

OTHERBreastfed infants

Breastmilk

Sponsors

Société des Produits Nestlé (SPN)
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
21 Days to 26 Days
Healthy volunteers
Yes

Inclusion criteria

* Written informed consent * Infants whose parent(s)/LAR who have reached the legal age of majority in the Philippines * Infants whose parent(s)/LAR are willing and able to comply with study requirements * Infants whose parent(s)/LAR who are able to be contacted directly by telephone throughout the study * Healthy term, singleton infant at birth * Between 21 to 26 days post-natal age at enrollment visit * Weight-for-length and head circumference-for-age z-scores are ≥ -3 and ≤ +3 according to WHO Child Growth Standards * Infants of parent(s)/LAR who have previously made the decision to breastfeed their infant at the time of enrollment

Exclusion criteria

* Infants with conditions requiring infant feedings other than those specified in the protocol * Infants receiving weaning foods or liquids * Infants who have a medical condition or history that could increase the risk associated with study participation or interfere with the interpretation of study results * Infants who are presently receiving or have received medications that could interfere with the interpretation of study results * Infants or infants whose parent(s)/LAR who cannot be expected to comply with the protocol or with study procedures

Design outcomes

Primary

MeasureTime frame
Stool Consistency Score155 days

Secondary

MeasureTime frameDescription
Fecal Microbiota Composition155 days
Changes in Weight from baseline to 155 days155 daysweight (kg)
Changes in Length from baseline to 155 days155 dayslength (cm)
Changes in Head Circumference from baseline to 155 days155 dayshead circumference (cm)

Countries

Philippines

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026